L. Raymond Reynolds, MD, FACP, FACE

Fellowship Director, Division of Endocrinology and Molecular Medicine
Clinical Director, Barnstable Brown Kentucky Diabetes and Obesity Center

Clinical interests

  • Endocrinology
  • Insulin Pump Therapy
  • Neck Ultrasound
  • Thyroid Nodules
  • Thyroid Ultrasound

L. Raymond Reynolds, MD, FACP, FACE

Fellowship Director, Division of Endocrinology and Molecular Medicine
Clinical Director, Barnstable Brown Kentucky Diabetes and Obesity Center

Biography

My name is Raymond Reynolds; I received my medical degree from the University of Kentucky, College of Medicine, Lexington. After internal medicine residency at the University of Cincinnati and two years of military service, I completed an endocrinology fellowship at the University of Kentucky, Lexington.

I am board certified by the American Board of Internal Medicine in Endocrinology and Metabolism and a Fellow of the American College of Physicians and American College of Endocrinology. I also have Endocrine Certification in Neck Ultrasound and am Director of the Endocrinology Fellowship Program. I am medical director of the Health Management Resources Weight Management program.

Faculty rank

Professor of Medicine

Education

Degree
University of Kentucky, College of Medicine, Lexington

Residency
University of Kentucky, Lexington
University of Cincinnati Medical Center

Fellowship
University of Kentucky, Lexington

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Endocrinology and Metabolism 
Fellow of the American College of Physicians
Fellow of the American College of Endocrinology
Endocrine Certification in Neck Ultrasound (ECNU)

Endocrinology

Medicine Specialties

Kentucky Clinic
Second Floor, Wing C
740 S. Limestone
Lexington KY 40536-0284

Call 859-323-2232
Fax 859-257-2634

Amenities
Dining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs

Kentucky Clinic Map (PDF, 616 KB) »
Directions to Kentucky Clinic Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Bhatt D, Reynolds LR. Keep Your Hands Off My Insulin Pump! The Dilemma of the Hospitalized Insulin Pump Patient. Am J Med. 2015 Sep;128(9):936-7.
    View in: PubMed
  2. LaBoone LM, McLarney JT, Reynolds LR. An interdepartmental collaboration to improve preoperative glycemic control. Hosp Pract (1995). 2014 Dec;42(5):83-8.
    View in: PubMed
  3. Qureshi A, Deakins DA, Reynolds LR. Obstacles to optimal management of inpatient hyperglycemia in noncritically ill patients. Hosp Pract (1995). 2012 Apr;40(2):36-43.
    View in: PubMed
  4. Anigbogu CN, Speakman RO, Silcox DL, Brown LV, Brown DR, Gong MC, Patwardhan AR, Reynolds LR, Karounos DG, Burgess DE, Baldridge BR, Randall DC. Extended longitudinal analysis of arterial pressure and heart rate control in unanesthetized rats with type 1 diabetes. Auton Neurosci. 2012 Sep 25; 170(1-2):20-9. PMID: 22809731.
    View in: PubMed
  5. Nasrallah SN, Reynolds LR. Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin? Clin Med Insights Endocrinol Diabetes. 2012; 5:31-7. PMID: 22879797.
    View in: PubMed
  6. Anderson JW, Reynolds LR, Bush HM, Rinsky JL, Washnock C. Effect of a behavioral/nutritional intervention program on weight loss in obese adults: a randomized controlled trial. Postgrad Med. 2011 Sep; 123(5):205-13. PMID: 21904103.
    View in: PubMed
  7. Randall DC, Speakman RO, Silcox DL, Brown LV, Brown DR, Gong MC, Patwardhan A, Reynolds LR, Karounos DG, Burgess DE, Anigbogu CN. Longitudinal analysis of arterial blood pressure and heart rate response to acute behavioral stress in rats with type 1 diabetes mellitus and in age-matched controls. Front Physiol. 2011; 2:53. PMID: 21904530.
    View in: PubMed
  8. Yalla NM, Reynolds LR. Hürthle cell thyroid carcinoma presenting as a "hot" nodule. Endocr Pract. 2011 May-Jun; 17(3):e68-72. PMID: 21454238.
    View in: PubMed
  9. Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol. 2010 Jul; 7(7):369-75. PMID: 20404853.
    View in: PubMed
  10. Reynolds LR. Comparing insulins detemir and glargine in type 2 diabetes: more similarities than differences. Commentary. Postgrad Med. 2010 Jan; 122(1):201-3. PMID: 20107306.
    View in: PubMed
  11. Yalla NM, Reynolds LR. Inpatient glycemic control: an evolving paradigm. Postgrad Med. 2009 May; 121(3):26-32. PMID: 19491537.
    View in: PubMed
  12. Reynolds LR, Tannock LR. Management of new-onset diabetes mellitus after transplantation. Postgrad Med. 2008 Jul; 120(2):60-6. PMID: 18654070.
    View in: PubMed
  13. Tannock LR, Reynolds LR. Management of dyslipidemia in patients after solid organ transplantation. Postgrad Med. 2008 Apr; 120(1):43-9. PMID: 18467808.
    View in: PubMed
  14. Reynolds LR, Cook AM, Lewis DA, Colliver MC, Legg SS, Barnes NG, Conigliaro J, Lofgren RP. An institutional process to improve inpatient glycemic control. Qual Manag Health Care. 2007 Jul-Sep; 16(3):239-49. PMID: 17627219.
    View in: PubMed
  15. Budsberg SC, Bergh MS, Reynolds LR, Streppa HK. Evaluation of pentosan polysulfate sodium in the postoperative recovery from cranial cruciate injury in dogs: a randomized, placebo-controlled clinical trial. Vet Surg. 2007 Apr; 36(3):234-44. PMID: 17461948.
    View in: PubMed
  16. Reynolds LR, Kingsley FJ, Karounos DG, Tannock LR. Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes. Diabetes Res Clin Pract. 2007 Aug; 77(2):180-7. PMID: 17239474.
    View in: PubMed
  17. Reynolds LR, Anderson JW. Practical office strategies for weight management of the obese diabetic individual. Endocr Pract. 2004 Mar-Apr; 10(2):153-9. PMID: 15256334.
    View in: PubMed
  18. Reynolds LR, Park AE, Miller RE, Karounos DG. Combined use of calcium infusion localization and a minimally invasive surgical procedure in the management of insulinoma. Endocr Pract. 2002 Sep-Oct; 8(5):329-34. PMID: 15251834.
    View in: PubMed
  19. Reynolds LR, Karounos DG. Emerging technology in diabetes mellitus: glucose monitoring and new insulins. South Med J. 2002 Aug; 95(8):914-8. PMID: 12190231.
    View in: PubMed
  20. Reynolds LR, Konz EC, Frederich RC, Anderson JW. Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus. Diabetes Obes Metab. 2002 Jul; 4(4):270-5. PMID: 12099976.
    View in: PubMed
  21. Reynolds LR. Reemergence of insulin pump therapy in the 1990s. South Med J. 2000 Dec; 93(12):1157-61. PMID: 11142448.
    View in: PubMed
  22. Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, Dunkle LM. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. J Acquir Immune Defic Syndr. 1999 Sep 1; 22(1):39-48. PMID: 10534145.
    View in: PubMed